July 2, 2026
10:04 pm

The History of Life Settlements: From Viaticals to a Regulated Market

The life settlement market traces back to the 1911 Supreme Court decision Grigsby v. Russell, which established that a life insurance policy is personal property its owner may sell — but the modern market emerged from the viatical settlements of the AIDS crisis in the late 1980s and matured into today’s regulated, institutional asset class over the following three decades. The journey runs from a $100 courtroom dispute through an improvised humanitarian marketplace, painful growing pains, landmark regulation, and finally institutionalization by pension funds and asset managers. Each era left rules and safeguards that shape how a policy is sold today.

This article walks the full timeline: the legal foundation, the viatical era, the pivot to senior settlements, the regulatory response, the 2008 reckoning, and the institutional market of the present.

In This Article

1911: Grigsby v. Russell Creates the Legal Foundation
The Late 1980s: The AIDS Crisis and the Viatical Era
The Late 1990s: The Pivot to Senior Life Settlements
The 2000s: Regulation Rises — and So Do Excesses
2008-2010: The Reckoning — LE Revisions, the Crisis, and the GAO
The 2010s to Today: The Institutional Era
What the History Teaches Today’s Policyholder
Frequently Asked Questions

The History of Life Settlements: From Viaticals to a Regulated Market

1911: Grigsby v. Russell Creates the Legal Foundation

The story begins with a modest transaction. John Burchard, unable to pay for surgery, sold his life insurance policy to his doctor, A.H. Grigsby, for $100 plus Grigsby’s agreement to pay the remaining premiums. When Burchard died, his executor (Russell) challenged Grigsby’s claim to the death benefit, arguing a policy could not validly be transferred to someone with no insurable interest in the insured’s life.

The case reached the U.S. Supreme Court, and in Grigsby v. Russell (1911), Justice Oliver Wendell Holmes ruled for the doctor. His reasoning established the two pillars the entire secondary market still stands on:

A life insurance policy is property. “Life insurance has become in our days one of the best recognized forms of investment and self-compelled saving,” Holmes wrote, and property ordinarily carries the right of sale.
Transferability creates value. Denying owners the right to sell would diminish what the asset is worth in their own hands — the insight that still explains why settlements typically pay multiples of surrender value.

Holmes drew the boundary that still polices the market: insurable interest is required when a policy is created — one cannot take out insurance on a stranger as a wager — but a validly issued policy may later be assigned freely. That distinction is the exact line separating legitimate settlements from prohibited stranger-originated life insurance (STOLI) a century later.

For most of the twentieth century, the right Grigsby recognized lay dormant. Policies were occasionally assigned privately, but no organized market existed: there were no buyers, no underwriting infrastructure, and no reason for one — until a public health catastrophe supplied a desperate demand for liquidity, as described in what is a life settlement.

The Late 1980s: The AIDS Crisis and the Viatical Era

The organized secondary market was born from tragedy. In the late 1980s, the AIDS epidemic left thousands of mostly young men facing terminal diagnoses, catastrophic medical costs, lost income — and, frequently, life insurance policies that would pay only after death, when the money could no longer help them.

Entrepreneurs recognized that Grigsby’s dormant property right could unlock those policies. Viatical settlement companies (from the Latin viaticum, provisions for a journey) began purchasing policies from terminally ill insureds at discounts to face value, paying cash immediately and collecting the death benefit later. For sellers, the trade was often transformative: money for treatment, housing, and dignity in their remaining months.

The viatical era’s characteristics differed sharply from today’s market:

Terminal illness was the trigger — life expectancies were typically measured in months, not years, making pricing crude but functional;
Buyers were often individuals purchasing whole policies or fractional interests, not institutions;
Regulation barely existed — few states had any statute addressing the transactions;
Pricing was inconsistent, with little underwriting science and wide variation in what similar sellers received.

The era also planted the seeds of its own problems. Fractional retail investment invited fraud; “clean-sheeting” schemes (obtaining policies by concealing diagnoses, then quickly selling them) abused contestability rules; and some operators preyed on desperate sellers. Then medicine intervened: the arrival of effective antiretroviral therapy in the mid-1990s dramatically extended the lives of many insureds — devastating returns for investors who had priced policies on short survival assumptions, and delivering the market’s first great longevity lesson. The full distinction between viaticals and modern settlements is covered in the viatical settlement complete guide.

The Late 1990s: The Pivot to Senior Life Settlements

As the viatical market contracted, its infrastructure — buyers, escrow practices, medical underwriting know-how — searched for a broader foundation. It found one in a much larger population: seniors who were not terminally ill but owned policies they no longer needed or could afford.

The economics were different but sound. An insured in their late seventies with chronic impairments might have a life expectancy of five to ten years — far longer than a viatical case, but short enough that a buyer paying well above surrender value could still model an attractive return, especially on universal life policies whose owners faced rising premiums. The life settlement, as distinct from the viatical settlement, was born: sales by insureds who were typically 65 or older, driven by financial planning rather than terminal diagnosis.

Several developments enabled the pivot:

Professional life expectancy underwriting. Specialized firms emerged to estimate longevity for impaired seniors — the discipline that evolved into today’s life expectancy assessments;
Universal life’s maturation. The UL policies sold heavily in the 1980s were, by the late 1990s, held by aging owners confronting premium escalation — a natural supply of sellers;
Early institutional interest. Investment banks and specialty finance firms began aggregating policies into portfolios, foreshadowing full institutionalization;
Broker intermediation. Intermediaries emerged to shop policies among competing buyers, beginning the auction dynamics described in broker vs. provider.

The pivot recentered the market on the population it still serves: senior policy owners weighing a settlement against lapse or surrender — the very comparison examined in life settlement vs. surrender.

Era	Defining Events	Market Character	Lasting Legacy
1911	Grigsby v. Russell decided by the Supreme Court	No organized market; dormant legal right	Policies established as transferable personal property
Late 1980s-mid 1990s	AIDS crisis; viatical settlement companies form	Terminal-illness sales; retail investors; minimal regulation	Proof of concept; first longevity-risk lesson via antiretroviral therapy
Late 1990s-early 2000s	Pivot to senior (non-terminal) policy sales	Life settlements distinct from viaticals; LE underwriting firms emerge	Senior-focused market; professional longevity estimation
2000s	NAIC model act revisions (2007); STOLI wave and crackdown	Rapid growth with regulatory build-out and excesses	Licensing, disclosures, escrow, rescission; 2-year seasoning rule
2008-2010	LE methodology lengthening; financial crisis; GAO-10-775	Losses, fund failures, consolidation	Dual LE reports; conservative pricing; federal documentation of consumer value
2010s-present	Institutional capital dominance; tertiary market depth; Rev. Rul. 2009-13 and TCJA tax clarity	Regulated institutional asset class; non-correlation validated	Today’s process: competitive auctions, 60-120 days, 10-35% of face typical

The Late 1990s: The Pivot to Senior Life Settlements

The 2000s: Regulation Rises — and So Do Excesses

The 2000s brought the market both its regulatory skeleton and its worst behavior, often in the same years.

The regulatory build-out. The National Association of Insurance Commissioners had adopted a Viatical Settlements Model Act in the 1990s; as the senior market grew, the NAIC substantially revised the framework — culminating in the 2007 revision now known as the Life Settlements Model Act. Its architecture became the national template: provider and broker licensing, mandated disclosures (including broker compensation), approved contract forms, escrow requirements, rescission windows of 15-30 days, privacy protections, and annual regulatory reporting. States adopted versions of it in waves, extending regulation to the overwhelming majority of the U.S. population — the framework maintained today by the NAIC and state insurance departments.

The STOLI excesses. Simultaneously, cheap capital and rising demand for policies spawned stranger-originated life insurance: promoters inducing seniors — often with upfront payments or “free insurance” — to take out large policies intended from inception for sale to investors. STOLI inverted Grigsby’s boundary: instead of selling a policy honestly acquired, it manufactured policies as wagers on strangers’ lives. Carriers sued, states legislated, and the practice was suppressed through explicit STOLI prohibitions and the now-standard requirement that a policy be in force 2 years (5 in some states) before settlement.

The dual legacy endures: robust consumer protections on one side, strict seasoning and insurable-interest screening on the other. Both are features a seller encounters directly in today’s process, as outlined in how life settlements work.

2008-2010: The Reckoning — LE Revisions, the Crisis, and the GAO

Three shocks in as many years transformed the market’s practices and reputation.

The life expectancy revisions (2008). Major medical underwriting firms, confronted with evidence that insureds were living longer than their tables predicted, lengthened their life expectancy methodologies substantially. Portfolios priced on the older, shorter estimates were abruptly worth less — more premium years remained, death benefits sat further away. Funds recorded losses, some collapsed, and litigation over valuation practices ran for years. The industry’s response became permanent doctrine: two independent life expectancy reports per policy, conservative blending, and systematic tracking of underwriters’ actual-to-expected accuracy — the safeguards explained in independent life expectancy reports.

The financial crisis (2008-2009). The crisis froze fundraising and forced levered holders to liquidate, but it also delivered the asset class’s defining proof: mortality-driven cash flows kept arriving on schedule while every correlated asset cratered. Non-correlation graduated from marketing claim to observed fact, seeding the institutional demand that followed.

The GAO examination (2010). Congress asked the Government Accountability Office to study the market, and GAO-10-775 documented both its consumer value — settlements paying multiples of surrender value — and its regulatory inconsistencies, recommending more uniform protection. The report accelerated state adoption of model-act standards and remains the most cited federal treatment of the market.

The reckoning purged the market’s speculative fringe. What survived was smaller, humbler, and structurally sounder — the foundation on which the institutional era was built.

The 2010s to Today: The Institutional Era

The market that emerged from the reckoning matured along every dimension during the 2010s and into the 2020s.

Institutional capital took over the buy side. Pension funds, asset managers, and insurance-linked securities platforms — allocators seeking returns non-correlated with equities — replaced the retail and speculative capital of earlier eras. Their diligence standards professionalized everything they touched, as described in who buys life insurance policies and institutional investors in life settlements.
The tertiary market deepened. Institutions began trading seasoned policies and whole portfolios among themselves, providing exit liquidity that in turn let buyers bid more confidently for new policies.
Underwriting and servicing industrialized. Dual LE reports, actual-to-expected auditing, premium optimization, and disciplined grace-period management (the 30-31 day window) became standard operating procedure.
Taxation clarified. IRS Rev. Rul. 2009-13 established the three-tier treatment of seller proceeds, and the 2017 Tax Cuts and Jobs Act corrected the basis rules in sellers’ favor — the regime detailed at the IRS and in our tax treatment guide.
Supply-side awareness grew. Several states enacted disclosure requirements encouraging carriers to inform lapsing policyholders of alternatives, and advisor education slowly shrank the awareness gap.

Low interest rates through the 2010s compressed buyers’ required returns and supported pricing; the sharp rate rises of 2022-2023 tested and repriced the market without breaking it, per how interest rates affect the market. Through both regimes, the demographic engine — the baby boom generation aging into qualification — kept enlarging the potential supply.

What the History Teaches Today’s Policyholder

History in this market is not trivia; each era deposited a rule or safeguard that a seller touches directly today.

From Grigsby: your policy is your property. The right to sell it is constitutional-grade settled law, not a loophole — and the insurable-interest boundary Holmes drew is why buyers scrutinize how a policy was originated.
From the viatical era: the humanitarian core of the market — liquidity when life circumstances change — and the first proof that longevity estimates can be badly wrong. Also the lesson that retail fractional investment invites abuse, which is why today’s buyers are institutions.
From the STOLI years: the 2-year (sometimes 5-year) seasoning requirement and origination scrutiny that protect the market’s legitimacy — and occasionally delay an honest seller’s transaction.
From the 2008 LE revisions: the two independent life expectancy reports and conservative pricing that shape every modern offer, per pricing mechanics.
From the model act era: the protections a seller should verify before signing anything — provider licensing, written disclosures including compensation, escrowed funds, and the 15-30 day rescission window.
From institutionalization: competitive auctions among professional buyers, which produce the typical outcomes of 10-35% of face value and 4-8 times surrender value over a 60-120 day process.

The market’s trajectory — from improvised and hazardous to regulated and institutional — is, on balance, a consumer-protection success story with honest scars. A policyholder exploring a sale today inherits a century of accumulated safeguards; the way to claim them is an informed, competitive, professionally advised process, beginning with the fundamentals in the complete guide to understanding life settlements.

Frequently Asked Questions

When did life settlements start and what was the first case?

The legal foundation dates to 1911, when the U.S. Supreme Court decided Grigsby v. Russell. A patient named John Burchard had sold his life insurance policy to his physician for $100 plus premium payments, and Justice Oliver Wendell Holmes upheld the sale, ruling that a life insurance policy is personal property its owner may transfer like any other asset. The organized market came much later: viatical settlements emerged during the AIDS crisis of the late 1980s, and modern senior-focused life settlements developed from the late 1990s onward.

What is the difference between a viatical settlement and a life settlement historically?

Viatical settlements, born in the AIDS crisis, involved terminally ill insureds — typically with life expectancies measured in months — selling policies to fund care and living expenses. Life settlements, which developed in the late 1990s, involve seniors who are generally 65 or older and not terminally ill, selling policies they no longer need or can afford, with life expectancies of several years. The distinction survives in state law: many statutes regulate both but apply different terms, and some states provide different tax and consumer-protection treatment for viatical transactions.

What was stranger-originated life insurance (STOLI) and why was it banned?

STOLI was a 2000s-era abuse in which promoters induced seniors — often with upfront cash or promises of free coverage — to take out large policies intended from the start to be transferred to investors. It inverted the rule from Grigsby v. Russell, which requires genuine insurable interest when a policy is created even though a valid policy may later be sold. States responded with explicit STOLI prohibitions and seasoning requirements — generally two years, sometimes five, before a policy can be settled — and carriers litigated aggressively. Legitimate buyers now screen carefully for origination defects.

What happened to the life settlement market in 2008?

Three shocks converged. Major life expectancy underwriting firms lengthened their methodologies after insureds proved to be living longer than predicted, marking down portfolios priced on shorter estimates and pushing some funds into failure. The global financial crisis simultaneously froze fundraising and forced levered holders to sell. Yet mortality-driven cash flows kept arriving through the crash, validating the asset’s non-correlation with markets. The aftermath produced today’s underwriting discipline — two independent life expectancy reports, conservative blending, and accuracy tracking — plus the consolidation that preceded institutional dominance.

What did the 2010 GAO report say about life settlements?

The Government Accountability Office’s report GAO-10-775, requested by Congress, examined the market’s structure, participants, and consumer outcomes. Its most cited finding documented the consumer value proposition: policy owners who settled received substantially more than the cash surrender value they would otherwise have taken — a multiple of it — though far less than face value. The report also mapped the inconsistent state regulatory landscape and recommended more uniform consumer protections, which accelerated state adoption of standards based on the NAIC Life Settlements Model Act.

How did life settlements become regulated?

Regulation grew in layers. The NAIC adopted a Viatical Settlements Model Act in the 1990s to address the first wave of transactions, then substantially revised the framework as the senior market grew, producing the 2007 Life Settlements Model Act. States adopted versions in waves through the 2000s and 2010s, and today the overwhelming majority of Americans live in states with licensing requirements for providers and brokers, mandated disclosures including compensation, escrow requirements, rescission windows of 15-30 days, privacy protections, and annual reporting to insurance departments.

When did institutional investors take over the life settlement market?

The transition accelerated after the 2008-2010 reckoning and defined the 2010s. As speculative and retail capital exited, pension funds, asset managers, and insurance-linked securities platforms — attracted by returns driven by mortality experience and non-correlated with equities — became the dominant sources of purchasing capital. Their diligence standards entrenched dual life expectancy reports, professional servicing, and portfolio diversification, while a deepening tertiary market of institution-to-institution portfolio trading added exit liquidity. Today’s consumer-facing market is effectively a regulated interface to institutional capital.

Why does the history of life settlements matter to someone selling a policy today?

Because every safeguard in today’s process is a scar from a past problem. The two-year seasoning rule answers the STOLI abuses; dual independent life expectancy reports answer the 2008 mispricing; licensing, disclosures, escrow, and 15-30 day rescission windows answer the viatical era’s inconsistencies; and the three-tier tax treatment of Rev. Rul. 2009-13 replaced genuine uncertainty. Knowing the history tells a seller exactly which protections to verify — and why a competitive, licensed, professionally advised process is the mechanism that delivers the market’s accumulated consumer value.

Find out what your policy is worth — free, confidential, no obligation.

A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.

Call (305) 209-7183 · Request a review online →

Table of Contents